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Abstract
In vivo imaging has revolutionized understanding of the spatiotemporal complexity that subserves
the generation of successful effector and regulatory immune responses. Until now, invasive
surgery has been required for microscopic access to lymph nodes (LNs), making repeated imaging
of the same animal impractical and potentially affecting lymphocyte behavior. To allow
longitudinal in vivo imaging, we conceived the novel approach of transplanting LNs into the
mouse ear pinna. Transplanted LNs maintain the structural and cellular organization of
conventional secondary lymphoid organs. They participate in lymphocyte recirculation and exhibit
the capacity to receive and respond to local antigenic challenge. The same LN could be repeatedly
imaged through time without the requirement for surgical exposure, and the dynamic behavior of
the cells within the transplanted LN could be characterized. Crucially, the use of blood vessels as
fiducial markers also allowed precise re-registration of the same regions for longitudinal imaging.
Thus, we provide the first demonstration of a method for repeated, noninvasive, in vivo imaging
of lymphocyte behavior.
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Introduction
Multiphoton laser scanning microscopy (MPLSM) has provided key insights into the
kinetics and dynamics of the cellular interactions that govern the initiation of adaptive
immune responses.1-5 These studies have been performed ex vivo on excised lymph nodes
(LNs) or in situ with surgically exposed LNs.6 However, long-term imaging is limited by the
effect of these procedures on the physiologic integrity of the LN, and longitudinal studies
have been impractical.1-5,7 We have therefore developed the novel approach of transplanting
a LN into the murine ear pinna to facilitate in vivo MPLSM directly through the skin,
allowing noninvasive, longitudinal imaging of cellular behavior in defined regions of the
same LN.
Although previous studies have established the ear pinna as a site for transplantation of
tissue such as spleen and heart,8-12 the concept of transplanting a LN into the ear pinna of a
mouse to facilitate imaging is entirely novel. Lymphoid tissue transfer has also long been
accepted as a suitable method to study the development of lymphoid structures in vivo.8,9,13
For example, the kidney capsule as a site of engraftment has proven invaluable for studying
the development and organization of lymphoid tissue,9,14 although relatively inaccessible
for in vivo imaging. In this regard, LN transplantation into the ear pinna has a clear
attraction. Here, we demonstrate that these transplanted LNs (tLNs) maintain the structural
features, cellular organization, and functional capabilities of conventional LNs.
Significantly, we show that tLNs have fully functional vascular and lymphatic supplies,
allowing lymphocyte recirculation, Ag drainage by the afferent lymphatics, and levels of T-
cell activation equivalent to those of normal LNs. Thus, our novel model provides a fully
functional LN in an accessible location that allows previously impossible repeated and long-
term in vivo MPLSM studies without surgical exposure/excision.
Methods
Animals
BALB/c (H-2d), C57BL/6J (CD45.2, H-2b), and Ly5.1/C57BL/6J (CD45.1, H-2b) mice
were used as recipients and donors. DO11.10 TCR transgenic (Tg) mice on a BALB/c
background were used as a source of Ag-specific T cells for experiments that show the tLNs
response to immunization.15 These TCR Tg T cells recognize ovalbumin323-339 in the
context of I-Ad MHC-II and are detectable with the KJ1-26 clonotypic Ab. hCD2-GFP mice
were used in MPLSM studies and express the green fluorescent protein (GFP) under the
control of the human CD2 promoter, a cell surface molecule expressed on T cells.16 All
animals were specified pathogen free and maintained under standard animal house
conditions at Strathclyde University or Glasgow University in accordance with Home Office
Regulations.
Adoptive transfer of Ag-specific lymphocytes and in vivo challenge
Adoptive transfers were performed as described previously.15 In some cases, cells were
labeled with the fluorescent dye CFSE (Invitrogen) or Cell Tracker Red (CMTPX;
Invitrogen) immediately before use.15 Twenty-four hours after the adoptive transfer mice
were challenged in the ear pinna with 50 μL of heat-aggregated ovalbumin or PBS as a
control. Heat-aggregated ovalbumin was prepared as previously described17 and was
administered subcutaneously at a concentration of 100 μg/mouse. Cell Dark red fluorescent
(660/680) 0.04-μm carboxylate-modified microspheres (FluoSpheres; Invitrogen) were used
in LN transplantation experiments to show lymphatic drainage. PBS-diluted microbeads
were injected subcutaneously into the outer edge of the ear pinna with tLNs.
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Lymph node transplantation
Lymph nodes were removed from newly weaned 3- to 4-week-old mice, removing any
excess fat, and placed into ice cold, sterile PBS (LNs were kept in this manner for no longer
than 1 hour before transplantation). Whole LNs were inserted into a skin flap created in the
ear pinna of the 8- to 12-week-old recipient. Veterinary-grade glue (Vetbond; 3M) was used
to seal the skin flap. Successful grafts were identified visually (Figure 1A-B) and confirmed
by soft tissue x-ray with the use of a Kodak FX Pro In-Vivo Imaging System (Carestream
Health; Figure 1C). The tLNs were dissected for analysis after 3-4 weeks. For histologic
studies, cervical, axillary or inguinal C57BL/6 donor LNs were engrafted to C57BL/6
recipients (all sources of LNs were able to produce viable tLNs, total replicates for this
equals 11). To show repopulation of the tLN by recipient lymphocytes, CD45.1+ donor LNs
were engrafted to CD45.2+ C57BL/6 recipients (n = 2 with 3 animals per group). For
showing activation of Ag-specific T cells in the tLN, BALB/c donor LNs were engrafted to
BALB/c recipients 3 weeks before adoptive transfer of DO11.10 TcR Tg T cells (n = 2). For
in vivo multiphoton imaging studies, C57BL/6 donor cervical LNs were engrafted to the ear
pinnae of hCD2-GFP recipients (n = 5).
Histopathology and immunofluorescence microscopy
Tissue samples in OCT embedding medium (Miles Diagnostic Division) were frozen in
liquid nitrogen and stored at −70°C. Tissue sections (8 μm) were prepared on a cryostat
(ThermoShandon) at −22°C. Sections were mounted onto SuperFrost slides (BHD) before
being air-dried and stored at −20°C until further processing. H&E (Sigma-Aldrich) staining
was performed on a Varistain 24-4 auto-staining processor (ThermoShandon). Tissue
samples were then mounted in DPX mounting fluid (VWR International) before
visualization by bright field microscopy. For fluorescence microscopy, tissue sections were
stained with anti-CCL21–FITC, anti-VCAM-1–biotin, anti-CD3-biotin, anti-CD11c–FITC
or biotin, anti-CD45.2–FITC, anti-CD4–FITC or pacific blue, anti-B220–FITC or biotin,
anti-IgM–Rhodamine Red, anti-BP3–biotin, or anti-gp38–biotin. Streptavidin Alexa Fluor
647 (Invitrogen) or streptavidin-FITC (BD Biosciences) was used in conjunction with
biotinylated primary Abs. Fluorescent images of the sections were captured with a Zeiss
LSM 510 Meta confocal microscope equipped with a 20×/1.0NA water-immersion objective
lens (Zeiss)
Flow cytometry
Flow cytometry was performed as described previously.18 Abs or appropriately labeled
isotype controls (anti-CD4–PerCP, anti-CD45.1–bio, anti-CD45.2–FITC, anti-CD8–APC,
anti-B220–FITC, FITC-Mouse IgG2a isotype control, and FITC/PerCP/APC-rat IgG2a, κ
isotype control; all BD Biosciences) and biotinylated KJ1.26 Ab) were added to each sample
at a dilution of 1:100 Ab. Biotinylated Abs were detected by incubation with fluorochrome-
conjugated streptavidin (BD Biosciences). Samples were analyzed with a FACSCanto flow
cytometer equipped with a 488-nm Argon laser and a 635-nm red diode laser (BD
Biosciences) and analyzed with FlowJo Version 9.4 software (TreeStar).
In vivo multiphoton imaging
Multiphoton imaging was performed with a Zeiss LSM7 MP system equipped with both a
10×/0.3 NA air and 20×/1.0NA water-immersion objective lens (Zeiss) and a tunable
titanium/ sapphire solid-state 2-photon excitation source (Chameleon Ultra II; Coherent
Laser Group). Excised LNs were bound with veterinary-grade glue (Vetbond; 3M) onto a
plastic coverslip and adhered with grease to the bottom of the imaging chamber and
continuously bathed in warmed (36.5°C), oxygenated CO2-independent medium. For in vivo
imaging, animals were anesthetized with fentanyl/ fluanisone (Hypnorm; Janssen Animal
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Health) and (Hypnovel; Roche) injectable anesthesia (10 mL/kg of a mix of fentanyl/
fluanisone/midazolam/ H20 at 1:1:2 by volume) given intraperitoneally. Core body
temperature was continuously monitored and maintained by a thermostatically controlled
heat mat. The ear of interest was mounted on a purpose-built stand with the use of
veterinary-grade glue (Vetbond; 3M), enabling warming of tissue throughout the experiment
and maintained at 37°C. At the end of imaging sessions, the veterinary glue was dissolved
with 70% ethanol, allowing repeated imaging at a later date. Intravenous injection of
nontargeted quantum dots (Qtracker 565 nontargeted quantum dots; Invitrogen) allowed
highlighting of blood vessels. tLNs were routinely 100-150 μm from the ear surface, with
images of cellular movement being made ~ 50 μm from the LN edge. Videos were acquired
for 15-30 minutes at an X-Y pixel resolution 512 × 512 with 1.5-μm increments in Z. Three-
dimensional tracking was performed with Volocity 5.5 (Perkin Elmer) after correction for
tissue drift, and values representing the mean velocity, displacement, and meandering index
were calculated for each object.
Statistics
Results are expressed as mean ± SD. Gaussian distribution was confirmed by D’Agostino
and Pearson omnibus normality test before significance being determined by 2-way
ANOVA. A value of P < .05 was regarded as significant.
Results
tLNs in the ear pinna are anatomically normal
Cervical, axillary, or inguinal C57BL/6J LNs from 3- to 4-week-old donors were engrafted
to the ear pinna of 8-week-old syngeneic recipients. Donor LNs were inserted into small
subdermal pockets on the ventral surface of the ear pinna. Mild, localized inflammation was
observed at the transplantation site for ≤ 7 days after the procedure. By 3 weeks after
transplantation, the superficial appearance of the ear pinna returned to normal, and the tLN/
site of engraftment was not obvious to the naked eye (Figure 1A). The tLN was visible
within the lightly dissected pinnae and maintained its original size and shape (Figure 1B).
By 3 weeks after transplantation, > 80% of the tLNs had engrafted and were readily
identifiable in live mice with the use of soft tissue x-ray (Figure 1C). These tLNs were
situated posterior to the auricular elastic cartilage and appeared histologically normal
(Figure 1D).
Because the stromal cell network is essential for maintaining LN size and cellularity,9 we
examined the structural integrity of this compartment after the engraftment procedure. No
marked differences were noted comparing control (non-tLN) with tLN for the distribution of
BP-3 (Figure 2A), a glycosylated cell surface protein expressed by reticular stromal cells of
secondary lymphoid tissue.19 We also detected both donor and recipient CD45+CD4+CD3−
inducer cells in the tLN (supplemental Figure 1, available on the Blood Web site; see the
Supplemental Materials link at the top of the online article), indicating that mechanisms
known to be important in maintaining cellular organization and function in normal LNs are
present in our tLN model.20,21 Accordingly, conventional anatomic compartmentalization of
T and B cells was evident in tLNs (Figure 2B). In addition, the overall proportion of CD4+,
CD8+ T cells and B220+ B cells was similar to control LNs (Figure 2C; supplemental Figure
2). CD11c staining showed normal distribution of dendritic cells throughout the paracortex
(supplemental Figure 3). The conventional structural organization and cellular composition
of tLNs indicates their capacity to support normal lymphocyte function, and a number of
parameters were next examined to confirm this.
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tLNs support lymphocyte recirculation
Lymphocyte recirculation is a crucial aspect of efficient immune surveillance.22 Naive T
and B cells enter LNs through high endothelial venules (HEVs). VCAM-1 is a key molecule
that promotes adhesion of lymphocytes to the vascular wall of the HEVs23 and was evident
in tLNs (Figure 3A). HEVs are also a source of CCL21,24,25 which actively recruits T cells
to the paracortical area of the LN. CCL21 was present in control and tLN tissue sections,
appearing throughout the T-cell area (Figure 3B). The presence of both HEVs and
appropriate chemotactic cues implies that tLNs would indeed support lymphocyte
recruitment.
To demonstrate this function, LNs were transplanted from C57BL/6J/CD45.1 mice into the
ear pinnae of C57BL/6J/CD45.2 recipients. Three weeks after engraftment, tLNs had been
repopulated with host CD45.2+ T cells with 82.5% of lymphocytes with tLNs being
CD45.2+ (Figure 3C). The peripheral LNs from the recipient mouse were also pooled and
analyzed for the presence of CD45.1+ lymphocytes originating from the tLN. As might be
expected very few CD45.1+ cells could be detected, but a very small population was present
(0.065%; Figure 3C). Thus, 3 weeks after transplantation, the tLN lymphocyte population
predominantly consisted of CD45.2+ lymphocytes. Normal recirculation by the tLN was also
confirmed with the use of the adoptive transfer of fluorescently labeled lymphocytes
(supplemental Figure 4).
Lymphatic drainage to the tLN
Afferent lymphatics are a critical component of immune surveillance, allowing LNs to
selectively localize and trap Ag and APCs trafficked there from peripheral tissues. The
presence of lymphatic vasculature supplying the tLN was assessed by examining the
expression of gp-38, a cell surface glycoprotein preferentially expressed by stromal cells in
T cell–dependent areas of secondary lymphoid organs and lymphatic endothelial cells.26
Lymphatic vessels that express gp-38+ were evenly distributed throughout the tissue and
were associated with areas of CD4+ staining in both control and tLN (supplemental Figure
5A-D), consistent with published reports of this glycoprotein being predominantly expressed
in T-cell areas of the LN.26 To directly examine the capacity of tLNs to drain material from
its new anatomical location, fluorescent microbeads (0.04 μm) were injected into the tip of
the ear pinna. Microbeads were easily detected in control, popliteal LNs after footpad
injection (supplemental Figure 5E-F) and 24 hours later were localized within the CD4+ T-
cell area of the LN. Similarly, microbeads could be detected in the tLN (supplemental
Figure 5G-H) after their injection into the tip of the ear pinna, confirming the ability of the
transplant to form functional afferent lymphatics in its new tissue location.
tLNs support naive T-cell activation
We used adoptive transfer of CFSE-labeled TCR Tg T cells (DO11.10) to determine
whether the tLN could facilitate activation of Ag-specific T-cell responses.15 CFSE dilution
and expansion of transferred cells was determined by flow cytometry 72 hours after
immunization with Ag. The proportion of CD4+KJ+ cells in both the control and tLN was
4.82% and 4.78% respectively (Figure 4A-D) and was reflected in the loss of CFSE signal,
indicative of cell division (Figure 4E-G). No difference in number of divisions between
challenged control or tLNs was observed, indicating equivalent proliferative responses
(summarized in Figure 4G). Overall, these data suggest that tLNs have a similar ability to
control LNs in supporting Ag-driven lymphocyte activation and proliferation.
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LN transplantation facilitates noninvasive, repeated imaging of dynamic lymphocyte
behavior
C57BL/6 LNs were engrafted to hCD2-GFP mouse ear pinnae for longitudinal multiphoton
imaging of GFP+ T cells in situ (Figure 5A-C; supplemental Videos 1-4). Recipient GFP+ T
cells could be directly observed through the skin in the tLN without the requirement for
surgical exposure, making longitudinal imaging feasible. Tracking studies found that
lymphocytes in the tLN exhibited a significantly (P < .001) lower average track velocity
(4.21 ± 2.3 μm/min) than those in excised popliteal LNs (8.97 ± 3.2 μm/min; Figure 5D;
supplemental Figure 6A). Directional travel of T cells was found to be comparable between
tLN and excised LNs with no significant difference in meandering index (Figure 5E;
supplemental Figure 6B). A significant reduction in displacement rate of tLN T cells was
also observed compared with excised LNs (P < .001; 1.80 ± 1.6 and 3.52 ± 2.2 μm/min,
respectively), probably reflecting the reduced velocity (Figure 5F; supplemental Figure 6C).
Comparable track velocities between excised LNs and those surgically exposed and
examined in situ have previously been reported. Although the T cells imaged in the tLNs
behaved in a similar manner as those in an excised LN, they were somewhat slower. To
replicate the effect of surgical exposure of LNs on T-cell behavior, we made small incisions
adjacent to the tLNs under observation and then reimaged the original region 40 minutes
later. A small increase in average track velocity (4.32 ± 2.1-6.74 ± 2.1 μm/min; P < .001)
after tissue damage (Figure 5D; supplemental Figure 6A) was evident; however, this was
still significantly lower than in excised LNs (P < .001). No significant alteration in
meandering index was detected (Figure 5E); however, surgical intervention produced similar
displacement rates to those seen in excised LNs (Figure 5F).
Because we did not have to perform surgery to permit imaging the tLN, we next sought to
determine the potential of our model to reimage the same tissue at different time points. We
chose to use blood vessels as fiduciary markers to guide reimaging of exactly the same
region of the tLN. By injecting nontargeted quantum dots intravenously we were able to
map blood vessels within the tLN during the initial imaging session. Injection of quantum
dots also allowed us to visualize blood flow in vivo in the tLN, further indicating the
successful formation of normal vasculature (Figure 6; supplemental Video 4). Importantly,
mapping of blood vessels enabled us to re-register the imaging field to the same anatomical
location in the tLN (Figure 7) as well as subsequently imaging lymphocyte behavior
(supplemental Video 4 for day 1 and supplemental Video 5 for day 3). These findings
emphasize the utility of this technique both for noninvasive repeat imaging in longitudinal
studies and for imaging at a defined locus.
Discussion
Here, we describe a novel technique in which a LN is transplanted into the ear pinna of a
mouse, providing a convenient anatomic location to facilitate in vivo MPLSM directly
through the skin. This approach circumvents the requirement for the LN to be removed or
surgically exposed and, significantly, has allowed the first longitudinal imaging of the same
LN.
Established tLNs showed the key anatomic, cellular, and functional characteristics of control
LNs. tLNs exhibited a normal stromal cell network, evidence of blood and lymphatic
supply, and the presence of the chemokine CCL21, associated with coordinating localization
of CD4+ T cells. CD45+CD4+CD3− LN inducer cells of both host and donor origin were
also detected within the tLN. These cells are known to play a critical role in LN
development through their interactions with stromal organizer cells, which induces the
release of chemokines and growth factors.27 Furthermore, their continued presence in adult
LNs is considered to be important in maintaining the organization of the LN. Presumably as
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a result of all of this, the key cell types required for the initiation of an adaptive immune
response, including T cells, B cells, and CD11c+ dendritic cells, were all detected in the
usual proportions and locations in the tLN.
We also demonstrated the presence of vascular and lymphatic supplies to the tLN and that
these were functional, capable of supporting lymphocyte recirculation and Ag drainage from
tissue sites. Lymphocyte recirculation was evidenced by the presence of recipient T cells
within tLN 3 weeks after transfer. Whether a tLN develops afferent lymphatic vessels
capable of draining Ag from its new anatomic location had never been previously explored
and was shown by injecting fluorescent microbeads into the peripheral tissue upstream of
the tLN. Previous studies had indicated that neonatal spleens transplanted into the ear pinna
were capable of responding to Ag challenge.8 However, unlike LNs, spleens do not possess
afferent and efferent lymphatic vessels, and the transplanted spleen was immunized directly
with a targeted injection of Ag, thus, circumventing the requirement for tissue-draining
lymphatic vessels.8 Growth factors capable of directly inducing the growth of lymphatic
vessels have been characterized and are up-regulated in response to environmental stress,
including hypoxia, and can regenerate lymphatic vessels after tissue damage.13 Therefore,
the tLN system may also be useful in studying angiogenesis.
Flow cytometric analysis showed that immunization with ovalbumin in the ear pinna led to
comparable Ag-specific T-cell proliferation in both the tLN and the control LN. This
conclusively showed that the tLN is fully functional, undergoing vascularization to receive
adoptively transferred T cells, draining Ag from a local injection site and supporting the
cellular interactions required for clonal expansion of Ag-specific T cells. To confirm this
final point, MPLSM was used to show T-lymphocyte movement within tLNs. Analysis of
MPLSM data showed basically similar movement characteristics in tLNs and control LNs.
Interestingly, lymphocytes in tLNs had reduced velocity and displacement rate compared
with excised LNs, whereas sham surgery near the tLN increased these parameters. It is
perhaps unsurprising that local trauma can affect lymphocyte function in draining LNs.
Sterile trauma is known to promote inflammatory mediator release,28 with dAMPs being
important receptors in this process. In addition, localized tissue trauma increases lymphatic
drainage, a process shown to increase intranodal levels of CCL21, potentially affected
dynamic cellular migration patterns.29 Our model avoids such effects that may complicate
the interpretation of data according to approaches with explantation or exposure of LNs.
Importantly, because surgery was not required to image the tLNs, we also showed, for the
first time, longitudinal imaging of the same LNs several days apart. For these studies, the
ability to image the same tissue area was particularly important. To achieve this, we used
blood vessels as fiduciary markers to re-register the imaging field to the same anatomic
location in the tLNs during subsequent imaging sessions, clearly showing the potential of
this technique for noninvasive, longitudinal imaging of cellular behavior.
In addition to visualizing spatially or temporally separated events, such as the physical
movement of cells entering and leaving LNs, this approach opens up the potential for
numerous other studies, including lymphangiogensis and vascularization; longitudinal
imaging of infection, vaccinations, and tumors; and combining this technique with
genetically modified animals to rapidly create compound transgenics.
In conclusion, we describe a new approach to imaging LNs in vivo with the use of MPLSM
without the need for surgical exposure. This approach has allowed us to perform the first
noninvasive, longitudinal imaging of lymphocyte behavior in vivo. We believe this model
will provide a powerful tool to investigate a wide range of lymphocyte/lymphocyte and
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lymphocyte/stromal cell interactions that regulate normal and pathologic immune responses
in vivo and the effect of therapeutic intervention on these processes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. LN transplantation to the ear pinna
LNs from 4-week-old donor mice were inserted into subdermal pockets made in the ear
pinna of adult C57BL/6 mice. The surgical incision was then sealed with veterinary-grade
adhesive. Three to 4 weeks after engraftment, ear pinnae were harvested and sectioned for
conventional histologic analysis. (A) Ear pinna before dissection. (B) Ear pinna containing
the tLN, black arrows indicate the tLN surrounded by blood vessels. (C) Soft x-ray imaging
identifies tLNs in ear pinna of live animals, marked by white arrows. (D) Ear pinna
containing the tLN stained with H&E (magnification, ×10).
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Figure 2. tLNs are anatomically normal
Three to 4 weeks after engraftment of syngenic LNs to C57BL/6 ear pinnae, tLNs were
harvested and sectioned for immunofluorescent staining. (A) Confocal imaging of control
and tLN showed equivalent BP3+ stromal cell (green) staining. CD4+ (blue) and IgM+ (red)
staining allows T- and B-cell areas to be visualized for reference. Scale bars represent 50
μm. (B) Segregation of T cells and B cells was also evidenced by compartmentalization of
CD4+ (green) T cell and IgM+ B cell (red) staining. Images shown are representative of 3
replicate mice; scale bars represent 100 μm. (C) tLNs were excised from the recipient
animals, and single cell suspensions were made. Cells were then stained for B220, CD8, and
CD4, and expression levels were determined by flow cytometry. These were compared
directly to control, non-tLNs. The proportions of CD4+, CD8+T cells, and B220+ B cells in
the tLN were found to be comparable with the control. Data show 6 replicate mice per group
(see supplemental Figure 2 for representative plots and gating strategies).
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Figure 3. tLN supports lymphocyte recirculation
Three to 4 weeks after syngenic LN engraftment to C57BL/6 ear pinnae, tLNs and control
LNs were harvested for sectioning and immunofluorescent staining. Control LNs and tLNs
were compared for expression of the vascular endothelial cell marker (A) VCAM-1 (green)
and (B) the chemokine CCL21 (green). Sections were also stained for CD4+ cells (blue) and
IgM+ B cells (red). Images shown are representative of 3 replicate mice. To confirm
recirculation, CD45.1 LNs were engrafted on CD45.2 recipients, and expression of CD45.1
and CD45.2 by control and tLN cells was assessed by flow cytometry. Scale bars denote 50
μm. (C) Representative flow cytometric plots show levels of CD45.1 and CD45.2 for both
control and tLN.
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Figure 4. Activation of T cells in the tLN
Incremental loss of CFSE intensity by KJ1.26+CD4+ cells 72 hours after heat-aggregated
ovalbumin (HAO) challenge in the ear showed proliferation of adoptively transferred
DO11.10T cells in BALB/c mice with established tLNs. Representative flow cytometric
plots of PBS-challenged cervical LN (A) and tLN (B). An expanded KJ1.26+CD4+
population is seen in both cervical (C) and tLN (D) after antigenic challenge. Incremental
loss of CFSE intensity of KJ1.26+CD4+ cells in the cervical LN and tLN (E-F), reflecting
Ag-specific proliferation that is summarized graphically (G). Data represent the mean of
triplicate samples ± SD (n = 2).
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Figure 5. MPLSM of tLN
C57BL/6 LNs were engrafted to the ear pinnae of hCD2-GFP mice. Three to 4 weeks after
engraftment, mice were anaesthetized, and the ear pinna was mounted on a heated stage (A).
The tLN was then imaged by MPLSM without the need for surgical exposure (ie, through
the intact ear). Recirculating GFP+ T cells in the tLN were imaged for ≤ 30 minutes (B), and
cells were tracked (C) to allow calculation of velocity (D), meandering index (E), and
displacement rate (F). After imaging the intact tLN, a surgical incision was made proximal
to the engraftment area. After a period of 40 minutes, the tLN was imaged again,
representing the LN after injury. Excised popliteal LNs from hCD2-GFP mice were imaged
in a perfusion chamber as a control. Data represent tracks generated from 3 independent
animals. Scale bars represent 40 μm. ***P < .001.
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Figure 6. MPLSM of tLN
C57BL/6 LNs were engrafted to the ear pinnae of hCD2-GFP mice. Three to 4 weeks after
engraftment, mice were anaesthetized, and the ear pinna was mounted on a heated stage.
Vasculature throughout the tLN was clearly visible after intravenous injection of
nontargeted Qdots (red); GFP+ cells (green); second harmonic signal (blue). (A) Extended
focus images of 60-μm z-stacks showing 2 different regions of the same tLN in left and
right panels (scale bars, 55 μm and 50 μm, respectively). (B left panel) Three-dimensional
reconstruction of blood vessels in the tLN. (B right) The corresponding extended focus
image is shown; scale bar, 50 μm. (C left) Three-dimensional reconstruction of a third tLN
showing vasculature. (C right) A representative optical section from the same z-stack is
shown; scale bar, 43 μm. Images were acquired with a 20×/1.0NA water-immersion
objective lens. Representative images from 3 independent animals are shown.
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Figure 7. tLNs can be repeatedly imaged in the same area days apart
C57BL/6 LNs were engrafted to the ear pinnae of hCD2-GFP mice. Three to 4 weeks after
engraftment, mice were anaesthetized, and the ear pinna was mounted on a heated stage.
Vasculature was visualized with nontargeted Qdots (red). Several regions of the tLN were
imaged where distinctive areas of vasculature were present. Two such areas are shown
(Regions 1 and 2). Mice were then recovered and returned to the animal facility. Animals
were then reimaged 3 days later. The same distinct areas of vasculature could be found in
the naive tLN, confirming that the same area could be imaged longitudinally. Feature blood
vessels are highlighted in blue. Scale bars in Region 1 images denote 50 μm. Scale bars in
Region 2 images denote 100 μm. Images were acquired with a 10×/0.3NA air objective lens.
Two representative regions are displayed from the same tLN.
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